RTW INVESTMENTS, LP Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$3.6T
Holdings
77
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (77 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 16,812,491 | $351.9B | 9.90% | |
| 2 | ALNYAlnylam Pharmaceuticals Inc | 1,681,645 | $249.1B | 7.01% | |
| 3 | PTCTPTC Therapeutics Inc | 3,963,120 | $201.1B | 5.66% | |
| 4 | —Dicerna Pharmaceuticals Inc | 7,152,918 | $181.7B | 5.11% | |
| 5 | ADVMCHFAdverum Biotechnologies Inc | 6,790,027 | $141.8B | 3.99% | |
| 6 | IMVTImmunovant Inc | 5,717,182 | $139.2B | 3.92% | |
| 7 | AXSMAxsome Therapeutics Inc | 1,658,316 | $136.4B | 3.84% | |
| 8 | MRTXEURMirati Therapeutics Inc | 1,087,726 | $124.2B | 3.49% | |
| 9 | RNAAvidity Biosciences Inc | 3,995,000 | $103.9B | 2.92% | |
| 10 | —Myokardia Inc | 936,931 | $90.5B | 2.55% | |
| 11 | 3M4Masimo Corp | 388,776 | $88.6B | 2.49% | |
| 12 | STOKStoke Therapeutics Inc | 3,544,248 | $84.5B | 2.38% | |
| 13 | BAXBaxter Intl Inc | 969,370 | $83.5B | 2.35% | |
| 14 | CERNCHFCerner Corp | 1,182,409 | $81.1B | 2.28% | |
| 15 | NTRANatera Inc | 1,529,128 | $76.2B | 2.14% | |
| 16 | —Translate Bio Inc | 3,716,994 | $66.6B | 1.87% | |
| 17 | RLMDRelmada Therapeutics Inc | 1,480,852 | $66.3B | 1.86% | |
| 18 | AXNX*Axonics Modulation Technolog | 1,883,257 | $66.1B | 1.86% | |
| 19 | FIXXEURHomology Medicines Inc | 4,352,190 | $66.1B | 1.86% | |
| 20 | BLUBellus Health Inc New | 5,970,230 | $61.5B | 1.73% | |
| 21 | PTGXProtagonist Therapeutics Inc | 3,383,208 | $59.7B | 1.68% | |
| 22 | TNDMTandem Diabetes Care Inc | 598,923 | $59.2B | 1.67% | |
| 23 | TXG10x Genomics Inc | 636,092 | $56.8B | 1.60% | |
| 24 | OYSTOyster Pt Pharma Inc | 1,909,360 | $55.1B | 1.55% | |
| 25 | VCELVericel Corp | 3,850,347 | $53.2B | 1.50% | |
| 26 | AGENEURAgenus Inc | 12,864,677 | $50.6B | 1.42% | |
| 27 | —Frequency Therapeutics Inc | 2,161,486 | $50.3B | 1.41% | |
| 28 | ESTAEstablishment Labs Hldgs Inc | 2,319,138 | $43.3B | 1.22% | |
| 29 | AVDLAvadel Pharmaceuticals plc | 5,306,570 | $42.9B | 1.21% | |
| 30 | DMTKQDermTech Inc | 2,855,765 | $37.8B | 1.06% | |
| 31 | MGNXMacroGenics Inc | 1,245,816 | $34.8B | 0.98% | |
| 32 | TCE2Celldex Therapeutics Inc New | 2,610,000 | $33.9B | 0.95% | |
| 33 | OPHTEURIVERIC bio Inc | 6,596,536 | $33.6B | 0.95% | |
| 34 | CSTLCastle Biosciences Inc | 803,510 | $30.3B | 0.85% | |
| 35 | PRQRProQR Thrapeutics N V | 4,902,785 | $29.8B | 0.84% | |
| 36 | NSTGEURNanoString Technologies Inc | 947,134 | $27.8B | 0.78% | |
| 37 | ADAPYAdaptimmune Therapeutics PLC | 2,600,000 | $26.0B | 0.73% | |
| 38 | WVEWAVE Life Sciences Ltd | 2,390,496 | $24.9B | 0.70% | |
| 39 | —Odonate Therapeutics Inc | 481,027 | $20.4B | 0.57% | |
| 40 | STAASTAAR Surgical Co | 308,904 | $19.0B | 0.53% | |
| 41 | APYXApyx Med Corp | 3,391,279 | $18.8B | 0.53% | |
| 42 | EP3OraSure Technologies Inc | 1,540,972 | $17.9B | 0.50% | |
| 43 | JNJJohnson & Johnson | 126,858 | $17.8B | 0.50% | |
| 44 | TELATela Bio Inc | 1,364,358 | $17.7B | 0.50% | |
| 45 | MISTMilestone Pharmaceuticals In | 4,315,102 | $16.3B | 0.46% | |
| 46 | XGNExagen Inc | 1,255,131 | $15.6B | 0.44% | |
| 47 | MDXGMiMedx Group Inc | 2,700,320 | $14.6B | 0.41% | |
| 48 | NEONeogenomics Inc | 445,000 | $13.8B | 0.39% | |
| 49 | —GenMark Diagnostics Inc | 935,206 | $13.8B | 0.39% | |
| 50 | CTMXCytomx Therapeutics Inc | 1,514,476 | $12.6B | 0.35% | |
| 51 | I9DNArbutus Biopharma Corp | 6,869,281 | $12.5B | 0.35% | |
| 52 | AMRSEURAmyris Inc | 3,103,535 | $12.4B | 0.35% | |
| 53 | RGNXRegenxbio Inc | 316,028 | $11.6B | 0.33% | |
| 54 | —La Jolla Pharmaceutical Co | 2,374,952 | $10.1B | 0.28% | |
| 55 | TMDXTransmedics Group Inc | 503,266 | $9.0B | 0.25% | |
| 56 | —Itamar Med Ltd | 457,218 | $8.5B | 0.24% | |
| 57 | CLSDUSDClearside Biomedical Inc | 3,917,622 | $7.4B | 0.21% | |
| 58 | ARGXargenx SE | 31,752 | $7.2B | 0.20% | |
| 59 | QUREUniqure NV | 157,282 | $7.1B | 0.20% | |
| 60 | INMDInmode Ltd | 250,000 | $7.1B | 0.20% | |
| 61 | RPTXRepare Therapeutics Inc | 225,000 | $7.0B | 0.20% | |
| 62 | BWAYBrainsway Ltd | 1,107,420 | $6.6B | 0.18% | |
| 63 | ARVNArvinas Inc | 174,118 | $5.8B | 0.16% | |
| 64 | —ARYA Sciences Acquistion Co | 500,000 | $5.8B | 0.16% | |
| 65 | —Lifesci Acquisition Corp | 500,000 | $5.5B | 0.15% | |
| 66 | —Chardan Healthcr Acqstn 2 Co | 350,000 | $3.7B | 0.10% | |
| 67 | PHGEBiomx Inc | 600,000 | $3.3B | 0.09% | |
| 68 | PSNLPersonalis Inc | 255,000 | $3.3B | 0.09% | |
| 69 | PRNProfound Med Corp | 174,193 | $3.0B | 0.08% | |
| 70 | —Progenity Inc | 275,000 | $2.5B | 0.07% | |
| 71 | NARIUSDInari Med Inc | 44,860 | $2.2B | 0.06% | |
| 72 | FLGTFulgent Genetics Inc | 75,000 | $1.2B | 0.03% | |
| 73 | —Motus Gi Hldgs Inc | 775,640 | $1.0B | 0.03% | |
| 74 | TWSTTwist Bioscience Corp | 18,473 | $837.0M | 0.02% | |
| 75 | BNRBurning Rock Biotech Ltd | 30,000 | $810.0M | 0.02% | |
| 76 | VRAYQViewray Inc | 150,000 | $336.0M | 0.01% | |
| 77 | PHGEBiomX Inc | 600,000 | $287.0M | 0.01% |